Purification of a protein from bovine plasma that binds to type 1 plasminogen activator inhibitor and prevents its interaction with extracellular matrix: evidence that the protein is vitronectinMIMURO, J; LOSKUTOFF, D. J.The Journal of biological chemistry (Print). 1989, Vol 264, Num 2, pp 936-939, issn 0021-9258Article

Binding of type 1 plasminogen activator inhibitor to the extracellular matrix of cultured bovine endothelial cellsMIMURO, J; LOSKUTOFF, D. J.The Journal of biological chemistry (Print). 1989, Vol 264, Num 9, pp 5058-5063, issn 0021-9258Article

Extracellular matrix of cultured bovine aortic endothelial cells contains functionally active type 1 plasminogen activator inhibitorMIMURO, J; SCHLEEF, R. R; LOSKUTOFF, D. J et al.Blood. 1987, Vol 70, Num 3, pp 721-728, issn 0006-4971Article

Release of α₂-plasmin inhibitor from plasma fibrin clots by activated caogulation factor XIII: its effect on fibrinolysisMIMURO, J; KIMURA, S; AOKI, N et al.The Journal of clinical investigation. 1986, Vol 77, Num 3, pp 1006-1013, issn 0021-9738Article

Expression of plasminogen activator inhibitor 2 in the adult and embryonic mouse tissuesKAWATA, Y; MIMURO, J; KANEKO, M et al.Thrombosis and haemostasis. 1996, Vol 76, Num 4, pp 569-576, issn 0340-6245Article

Monoclonal antibodies to discrete regions in α₂-plasmin inhibitorMIMURO, J; KOIKE, Y; SUMI, Y et al.Blood. 1987, Vol 69, Num 2, pp 446-453, issn 0006-4971Article

Fibrinogen Niigata with impaired fibrin assembly : An inherited dysfibrinogen with a Bβ Asn-160 to Ser substitution associated with extra glycosylation at Bβ Asn-158SUGO, T; NAKAMIKAWA, C; NAGAI, K et al.Blood. 1999, Vol 94, Num 11, pp 3806-3813, issn 0006-4971Article

Interactions between the finger and kringle-2 domains of tissue-type plasminogen activator and plasminogen activator inhibitor-1KANEKO, M; SAKATA, Y; MATSUDA, M et al.Journal of biochemistry (Tokyo). 1992, Vol 111, Num 2, pp 244-248, issn 0021-924XArticle

Differential binding of plasminogen to crosslinked and noncrosslinked fibrins: its significance in hemostatic defect in factor XIII deficiencySAKATA, Y; MIMURO, J; AOKI, N et al.Blood. 1984, Vol 63, Num 6, pp 1393-1401, issn 0006-4971Article

Morphological assessment of the luminal surface of olfactory epithelium in mice deficient in tissue plasminogen activator following bulbectomyMAKINO, N; OOKAWARA, S; MIMURO, J et al.Journal of laryngology and otology. 2012, Vol 126, Num 11, pp 1114-1120, issn 0022-2151, 7 p.Article

Developmental expression of plasminogen activator inhibitor-1 associated with thrombopoietin-dependent megakaryocytic differentiationMADOIWA, S; KOMATSU, N; MIMURO, J et al.Blood. 1999, Vol 94, Num 2, pp 475-482, issn 0006-4971Article

Reversible interactions between plasminogen activators and plasminogen activator inhibitor-1MIMURO, J; KANEKO, M; MURAKAMI, T et al.Biochimica et biophysica acta. Protein structure and molecular enzymology. 1992, Vol 1160, Num 3, pp 325-334, issn 0167-4838Article

Retinal pigment epithelial cells produce a latent fibrinolytic inhibitor that is antigenically and biochemically related to type 1 plasminogen activator inhibitor produced by vascular endothelial cellsCAMPOCHIARO, P. A; MIMURO, J; SUGG, R et al.Experimental eye research. 1989, Vol 49, Num 2, pp 195-203, issn 0014-4835Article

The plasminogen activator inhibitor-1 binding site in the kringle-2 domain of tissue-type plasminogen activatorKANEKO, M; MIMURO, J; MATSUDA, M et al.Biochemical and biophysical research communications (Print). 1991, Vol 178, Num 3, pp 1160-1166, issn 0006-291XArticle

Level of protein C determined by combined assays during disseminated intravascular coagulation and oral anticoagulationMIMURO, J; SAKATA, Y; WAKABAYASHI, K et al.Blood. 1987, Vol 69, Num 6, pp 1704-1711, issn 0006-4971Article

Type 1 plasminogen activator inhibitorLOSKUTOFF, D. J; SAWDEY, M; MIMURO, J et al.Progress in hemostasis and thrombosis. 1989, Vol 9, pp 87-115, issn 0362-6350Article

Recombinant adeno-associated virus vector-transduced vascular endothelial cells express the thrombomodulin transgene under the regulation of enhanced plasminogen activator inhibitor-1 promoterMIMURO, J; MURAMATSU, S; HAKAMADA, Y et al.Gene therapy (Basingstoke). 2001, Vol 8, Num 22, pp 1690-1697, issn 0969-7128Article

A new type of Ser substitution for γ Arg-275 in fibrinogen Kamogawa I characterized by impaired fibrin assemblyMIMURO, J; KAWATA, Y; MATSUDA, M et al.Thrombosis and haemostasis. 1999, Vol 81, Num 6, pp 940-944, issn 0340-6245Article

Monocytes modulate the fibrinolytic balance of endothelial cellsFUNAYAMA, H; SAKATA, Y; KITAGAWA, S.-L et al.Thrombosis research. 1997, Vol 85, Num 5, pp 377-385, issn 0049-3848Article

Identification of the plasminogen activator inhibitor-1 binding heptapeptide in vitronectinMIMURO, J; MURAMATSU, S.-I; KURANO, Y et al.Biochemistry (Easton). 1993, Vol 32, Num 9, pp 2314-2320, issn 0006-2960Article

Inhibitors of urokinase and thrombin in cultured neural cellsWAGNER, S. L; LAU, A. L; NGUYEN, A et al.Journal of neurochemistry. 1991, Vol 56, Num 1, pp 234-242, issn 0022-3042, 9 p.Article

cDNA for bovine type 1 plasminogen activator inhibitor (PAI-1)MIMURO, J; SAWDEY, M; HATTORI, M et al.Nucleic acids research. 1989, Vol 17, Num 21, issn 0305-1048, 8872 [1 p.]Article

Clot lysis induced by a monoclonal antibody against α₂-plasmin inhibitorSAKATA, Y; EGUCHI, Y; MIMURO, J et al.Blood. 1989, Vol 74, Num 8, pp 2692-2697, issn 0006-4971, 6 p.Article

Expression of human coagulation factor VIII in adipocytes transduced with the Simian immunodeficiency virus agmTYO1-based vector for hemophilia A gene therapyOGATA, K; MIMURO, J; SAKATA, Y et al.Gene therapy (Basingstoke). 2004, Vol 11, Num 3, pp 253-259, issn 0969-7128, 7 p.Article

A γ Gly-268 to Glu substitution is responsible for impaired fibrin assembly in a homozygous dysfibrinogen kurashiki INIWA, K; TAKEBE, M; MATSUDA, M et al.Blood. 1996, Vol 87, Num 11, pp 4686-4694, issn 0006-4971Article